But the Hawks bounced back, picking up a strong 8-1 victory over Grapevine Friday. Birdville (7-2) sits at second place in ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug ...

April 1 (Reuters) - The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up its next battle with rival Novo Nordisk for the millions of Americans seeking highly effective GLP-1 ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

The brief reign of Novo Nordisk’s Wegovy pill as the lone oral GLP-1 approved for obesity has ended as Eli Lilly’s orforglipron cruised past an FDA green light Wednesday. Now christened Foundayo, the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Centessa’s lead asset has already demonstrated positive results in Phase II studies across a range of sleep-wake cycle conditions. Credit: Michael Vi/Shutterstock.com. Eli Lilly will acquire ...

Eli Lilly has made yet another deal, this time buying a drug company that’s developing a therapy for narcolepsy for up to $7.8 billion. It’s acquiring Centessa Pharmaceuticals, which is working on ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. US drugmaker Eli Lilly has signed a $2bn deal with a Hong Kong-listed company that uses AI for drug ...

Under the deal, announced Sunday, Insilico is eligible for $115 million in upfront payments; other milestones could bring the value to $2.75 billion, plus tiered royalties on future sales. Eli Lilly & ...